Shifa Tameer-e-Millat University
Islamabad, Pakistan
NCT Number: NCT07668245
This RCT will determine the effects of attention focus training which is a comprehensive intervention to improve cognitive outcomes. Attention is one of the major cognitive outcome and problems with attention can deteriorate the quality of life of people suffering from stroke. Intervention will be provided for 4 weeks. Outcomes will be assessed at baseline and after provision of intervention.
Trial opening soon.
Get NotifiedUp to 55 year
All sexes
Interventional
Not applicable
Islamabad, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Focused attention (auditory target detection), Sustained attention (letter cancellation), Selective attention (cancellation with distractors), Alternating attention (number-letter switching)
Positioning and bed mobility, sitting balance training, standing training
Time frame: Baseline and post 4 weeks of intervention
Test of Everyday Attention (TEA) consists of multiple subtests assessing different aspects of attention. There is no single overall score with a defined minimum and maximum range. Each subtest has its own scoring range and is interpreted using age-adjusted normative data and percentile ranks. For all subtests, higher scores generally indicate better attentional performance.
Time frame: Baseline and post 4 weeks of intervention
Stroke Impact Scale (SIS) scores range from 0 to 100 for each domain. A score of 0 indicates greatest impact of stroke or complete inability to perform tasks within that domain, while a score of 100 indicates no disability, no difficulty performing tasks, and the best possible outcome. Higher scores indicate better functioning and less impact of stroke.
Contact information is provided by the study sponsor or research team.
Shifa Tameer-e-Millat University
Other
Acronym: AQoLStroke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07705256
Brain Diseases, Cardiovascular Diseases
London, United Kingdom
View Trial DetailsNCT07741669
Brain Diseases, Cardiovascular Diseases
Beijing, China
View Trial DetailsNCT07735676
Brain Diseases, Cardiovascular Diseases
Dhaka, Bangladesh
View Trial DetailsNCT07735702
Brain Diseases, Cardiovascular Diseases
Dhaka, Bangladesh
View Trial Details